Ipca Laboratories Conducts Walk-In for Freshers in Quality Control
7 January 2026

Ipca Laboratories Conducts Walk-In for Freshers in Quality Control

Upon successful completion of the training, selected candidates will be absorbed at various Ipca Laboratories locations as per compatibility and skills
7 January 2026
Senores Pharmaceuticals Hiring: F&D, ADL, QC, Regulatory Affairs
Solid Oral Formulation Development, QbD, Scale-Up, Pilot Batches & Tech Transfer. Literature Review & Excipient Compatibility.
7 January 2026
Europe Greenlights Easier-to-Use Shingrix Vaccine Format for Shingles Prevention

GSK has announced a significant regulatory milestone in adult immunisation with the European Commission’s approval of a new prefilled syringe presentation for its widely used shingles vaccine, Shingrix. This updated format is designed to simplify the administration process for healthcare professionals by removing the need to mix components before injection — a step required in the current two-vial version. The approval paves the way for rollout across EU countries throughout 2026.

7 January 2026
Dual-Drug Breakthrough: A new pathway to treat Liver Fibrosis
Researchers have identified a promising new treatment strategy for liver fibrosis, a chronic condition that can lead to cirrhosis and liver cancer, by combining two well-known drugs. Preliminary findings suggest that using silybin together with carvedilol produces a powerful synergistic effect significantly stronger than either drug alone, against the cellular processes that drive scar tissue formation in the liver.
7 January 2026
Infant gut molecules offer clues to type 1 Diabetes risk
In a groundbreaking study, scientists have uncovered a new class of gut-derived molecules in infancy that could reshape how researchers understand the development of type 1 diabetes. The international research team, led by experts at the University of Turku and Örebro University, investigated stool samples from more than 300 children between the ages of 3 and 36 months, all of whom had a genetic predisposition for type 1 diabetes.
6 January 2026
Join Government Medical College and Hospital - Opportunities for Pharmacy Graduates
BSc, MLT/BSc, Nursing/ BPH / B.Pharma / MSW / MCA, Experience in household or facility level data collection in health care research.
6 January 2026
Government Health Department invites applications for Pharmacists
Degree or Diploma in Pharmacy and Registration in CG Pharmacy Council. vacant posts by the Government for the smooth operation of health services
6 January 2026
Antitubercular Drug Research opportunities at MAHE for Pharmacy candidates
MSc/ MPharm/ PharmD/ MTech Laboratory technology / Microbiology / Molecular biology / Biotechnology / Pharmacy Practice preferred
6 January 2026
Research Opportunity in Mycobacterium tuberculosis at NIPER for Life Sciences & Pharma Candidates
Postgraduate in the field of Life Sciences or Pharmaceutical Sciences or any other allied Life sciences. Exploiting synthetic lethality of type II NADH dehydrogenases for complete sterilization of Mycobacterium tuberculosis
6 January 2026
ECHS, Government Defence Organisation Invites Applications for Pharmacist
B.Pharm or Diploma in Pharmacy. ECHS invites applications to engage following staff on contractual basis in ECHS Polyclinic Nagaon
6 January 2026
Primary Health Centers Openings for Pharmacists

List of the following vacancies on contract basis for the newly started Sembatti Primary Health Center (Aruppukkottai area) and Ilupbaiyur Primary Health Centers (Narikudi area) in Virudhunagar district.

Post : Pharmacist

6 January 2026
MAHE Research Careers for Pharmacy, Life Sciences, Biotechnology & Microbiology
BSc / MSc / MPharm / PharmD / MTech (Laboratory technology / Microbiology / Molecular biology / Biotechnology / Pharmacy Practice preferred).
6 January 2026
Cancer Research Fellowship Opportunities for Pharmacy and Life Sciences Candidates
M.Sc. (Life Sciences: Biochemistry, Biotechnology, or any branch of Life Sciences) degree holders. OR MBBS/BDS/MS Pharm/M. Pharma/ME/M. Tech degree holders.
6 January 2026
Fellowship Opportunity for Pharma Professionals at NIPER
M. Pharm. or M.S. Pharm. or M. Sc. with 1 year research experience or M. Tech. Strong Python programming skills with hands-on experience of using scientific Python libraries.
6 January 2026
Research Opportunities at All India Institute of Medical Sciences
Project Research Scientist-I under ICMR- funded project titled Evaluation of novel dipstick based molecular techniques for early detection of Gram- negative ESKAPE organisms and antimicrobial resistance genes in bum wounds.
6 January 2026
Career Opportunities in Parenteral QMS at Sun Pharma
Master of Pharmacy Participation in Investigations, Root cause analysis and proposing relevant CAPAs against OOS: OOT: incident, and change control complaints and audit observations to QMS team.
6 January 2026
Hetero hiring professionals in the Formulation Quality Control, ARD, Production & Packing department
Hetero is one of worlds leading producers of key Active Pharmaceutical Ingredients (APIs) and generic formulations with presence in 140 countries and backed by 30 years of experience in the pharma sector.
6 January 2026
Torrent Pharmaceuticals hiring for Product Management Team
Design and implement overall marketing and communication strategies for assigned brands. Conduct sales and marketing data analysis to support business decisions.
6 January 2026
FDA nods first pediatric therapy for rare blood disorder aTTP

The U.S. Food and Drug Administration has approved Cablivi (caplacizumab-yhdp) for pediatric patients 12 years and older suffering from acquired thrombotic thrombocytopenic purpura (aTTP), marking the first time a treatment has been authorized for this extremely rare condition in children.

6 January 2026
ScinoPharm gets U.S. FDA approval for Multiple Sclerosis treatment
ScinoPharm Taiwan has clinched a landmark regulatory victory by securing U.S. Food and Drug Administration (FDA) approval for its Glatiramer Acetate Injection, a treatment used to manage multiple sclerosis (MS), the company announced
Subscribe to